Recently, we reported that activated B cells are increased in ET patients, and can facilitate platelet production mediated by cytokines, such as interleukin (IL)-1β and IL-6 regardless JAK2V617F mutational status [23]. Here, IL1B is linked to essential thrombocythemia.